'Average risk' presentation slideshows

Discounted Cashflow Valuation: Equity and Firm Models

Discounted Cashflow Valuation: Equity and Firm Models. Aswath Damodaran. Summarizing the Inputs. In summary, at this stage in the process, we should have an estimate of the

1.35k views • 91 slides

Discounted Cashflow Valuation: Equity and Firm Models

Discounted Cashflow Valuation: Equity and Firm Models. Aswath Damodaran. Summarizing the Inputs. In summary, at this stage in the process, we should have an estimate of the

1.16k views • 91 slides

CURRENT SCREENING RECOMMENDATIONS

CURRENT SCREENING RECOMMENDATIONS. Marie Denise Gervais, M.D. Department of Family Medicine Assistant Clinical Professor UM/Miller School of Medicine. "The superior physician helps before the early budding of the disease...". Chinese Emperor Huang Ti ~ 2600 BC. Aims and Objectives.

735 views • 55 slides

CHAPTER 5 Risk and Rates of Return

793 views • 50 slides

CHAPTER 5 Risk and Rates of Return

649 views • 50 slides

Colorectal Cancer Screening: Costs, Compliance and Couric

Colorectal Cancer Screening: Costs, Compliance and Couric. John Inadomi Cyrus E. Rubin Professor and Head Division of Gastroenterology Department of Medicine University of Washington. Colorectal Cancer Screening Agenda. Is there a preferred screening strategy?

788 views • 47 slides

PPS603 Microeconomics of International Development Policy

631 views • 46 slides

Strategic Risk Communication Involving Environmental Health Issues

Strategic Risk Communication Involving Environmental Health Issues. Breast Cancer and Environment Pre-Conference November 8, 2005 Michigan State University, Lansing, MI Katherine McComas , PhD Department of Communication Cornell University, Ithaca, NY. What is Risk?.

517 views • 45 slides

THE QUEST FOR BETTER DEFINITION OF THE PRODUCT LIFE CYCLE - AND CONSEQUENCES FOR LICENSING

THE QUEST FOR BETTER DEFINITION OF THE PRODUCT LIFE CYCLE - AND CONSEQUENCES FOR LICENSING. John Ansell John Ansell Consultancy Thame, Oxfordshire, UK. LES Chelsea Village 27 June 2003. THE QUEST FOR BETTER DEFINING THE PLC - AND CONSEQUENCES FOR LICENSING .

512 views • 36 slides

Chapter 9: The Cost of Capital

Chapter 9: The Cost of Capital. The Cost of Capital:. Chapter Outline:. The Purpose of the Cost of Capital Capital Components Calculating Component Costs of Capital Calculating the WACC Factors that affect the cost of capital Problem areas in cost of capital.

635 views • 31 slides

Bloodborne Pathogen Training

Bloodborne Pathogen Training. Introduction to the problem of Bloodborne Pathogens. Healthcare Providers and those working with potentially infectious fluids need to be especially concerned with three major bloodborne pathogens: Hepatitis B Virus: HBV Hepatitis C Virus: HCV

1.06k views • 28 slides

Colorectal Cancer Screening PROGRAMS AND STRATEGIES in Canada Environmental Scan

Colorectal Cancer Screening PROGRAMS AND STRATEGIES in Canada Environmental Scan. March 2013. Background.

358 views • 27 slides

Cervical Cancer Screening Update

Cervical Cancer Screening Update. Based on the 2012 Recommendations (ASCCP) Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.

570 views • 27 slides

Colorectal Cancer Screening and Surveillance

Colorectal Cancer Screening and Surveillance. Johnny Altawil , M.D. PGY- VI 09/19/2012. Why should we screen for colorectal cancer?. Why should we screen?. Common: Worldwide, CRC is 2 nd in women and 3 rd in men Over 600,000 deaths in 2008

727 views • 24 slides

Bloodborne Pathogens

Bloodborne Pathogens. Preventing Transmission of Bloodborne Pathogens. Are transmissible in health care settings Can produce chronic infection Are often carried by persons unaware of their infection.

379 views • 22 slides

Screening for breast cancer

Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences . Screening for breast cancer. Women at average risk for breast cancer Annual screening from age 40.

505 views • 20 slides

Dengue Transfusion Risk Model

Dengue Transfusion Risk Model. Lyle R. Petersen, MD, MPH Brad Biggerstaff, PhD Division of Vector-Borne Diseases Centers for Disease Control and Prevention Blood Products Advisory Committee Meeting December 14, 2010. Agenda. Arbovirus risk model

294 views • 18 slides

284 views • 17 slides

Fighting back Against Colon Cancer

304 views • 16 slides

IAL Case #3: Colon Cancer

IAL Case #3: Colon Cancer. Stephanie Hattoy & Lindsey Lemke. Question #1. What are the risks for colon cancer? Describe screening recommendations. Risk for Colon Cancer. Average risk Age ? 50 No history of adenoma No history of inflammatory bowel disease Negative family history.

482 views • 16 slides